Opus Genetics, Stock Today

IRD Stock   1.10  0.09  8.91%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 75

 
High
 
Low
High
Opus Genetics, is trading at 1.10 as of the 26th of November 2024, a 8.91% up since the beginning of the trading day. The stock's lowest day price was 1.02. Opus Genetics, has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Opus Genetics, symbol was changed from OCUP on 24th of October 2024. Equity ratings for Opus Genetics, are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
IPO Date
23rd of May 2005
Category
Healthcare
Opus Genetics, is entity of United States. It is traded as Stock on NASDAQ exchange. More on Opus Genetics,

Moving together with Opus Stock

  0.61DNTH Dianthus TherapeuticsPairCorr
  0.64VERU Veru Inc Fiscal Year End 13th of December 2024 PairCorr

Moving against Opus Stock

  0.69VAXX VaxxinityPairCorr
  0.58SABSW SAB BiotherapeuticsPairCorr
  0.55VCYT VeracytePairCorr
  0.49DRUG Bright Minds BiosciencesPairCorr
  0.45VERA Vera TherapeuticsPairCorr
  0.37VANI Vivani MedicalPairCorr

Opus Stock Highlights

Older SymbolOCUP
CEO DirectorMBA MD
Old NameGroupe IRD
Business ConcentrationPharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities3.8 MM
Notably Down
Slightly volatile
Total Assets40.3 M53.9 M
Way Down
Slightly volatile
Total Current Assets40.3 M53.9 M
Way Down
Slightly volatile
Opus Genetics, (IRD) is traded on NASDAQ Exchange in USA. It is located in 37000 Grand River Avenue, Farmington Hills, MI, United States, 48335 and employs 14 people. Opus Genetics, was previously known as Ocuphire Pharma and was traded on NASDAQ Exchange under the symbol OCUP. Opus Genetics, is listed under Pharmaceutical Products category by Fama And French industry classification. The company runs under Healthcare sector within Biotechnology industry. Opus Genetics, generates negative cash flow from operations
Check Opus Genetics, Probability Of Bankruptcy

Opus Genetics, Historical Income Statement

The current year's Total Other Income Expense Net is expected to grow to about 2 M, whereas Net Interest Income is forecasted to decline to (1.4 M). View More Fundamentals

Opus Stock Against Markets

Opus Genetics, Corporate Management

Joseph MBAChief OfficerProfile
Bernhard MBASenior SecretaryProfile
Ashwath JayagopalChief OfficerProfile
Bindu ManneHead CommercializationProfile
MAcc CPASenior FinanceProfile
Nirav CFAChief OfficerProfile
When determining whether Opus Genetics, is a strong investment it is important to analyze Opus Genetics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Opus Genetics,'s future performance. For an informed investment choice regarding Opus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Opus Genetics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics,. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opus Genetics, is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics,'s value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics,'s market value can be influenced by many factors that don't directly affect Opus Genetics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.